UNSPSC 51391608: Ractopamine

This classification denotes a veterinary beta-adrenergic agonist with the molecular formula C18H23NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 57370OZ3P1, chemically known as benzenemethanol, 4-hydroxy-alpha-(((3-(4-hydroxyphenyl)-1-methylpropyl)amino)methyl)- but generally known as ractopamine, which bears US NIH Compound Identifier 56052. European Medicines Agency schedules Ractopamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10240MIG.

UNSPSC 51391608 Ractopamine is a Commodity code that in recent state and local procurement activity covers pharmaceutical products and medical supplies used in public health and community health initiatives, though the code's nominal scope (ractopamine, a livestock growth promotant) does not align with the actual purchases being solicited. The recent opportunities tracked under this code show state and local governments procuring naloxone, drug deactivation systems, and pharmacy benefit program services—acquisitions that fall outside ractopamine's traditional livestock pharmaceutical domain. Issuing bodies include county health departments and state health and human services agencies seeking to support opioid response and pharmacy management programs.

Seminole County, Florida issued IFB60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, with response due July 26, 2023; the Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for direct-to-manufacturer prescription fulfillment programs outside traditional pharmacy benefit manager arrangements. Geographic activity centers on Florida and Texas. The code shows a meaningful mismatch between its UNSPSC designation and the actual health-care and pharmaceutical-supply work being procured—ractopamine does not appear in either solicitation, suggesting the code may have been applied in error or the category's scope has drifted from its original livestock-pharmaceutical intent in state and local procurement workflows.